One day, bionics research could result in neural prostheses that augment or restore damaged or lost functions of the nervous system – restore vision, healing spinal cord injuries, and ameliorate ...
FREDERICK, Md.--(BUSINESS WIRE)--BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it filed an application with the U.S ...
Researchers in Carnegie Mellon University's Soft Machines Lab have developed a silver-hydrogel composite that has high electrical conductivity and is capable of delivering direct current while ...
FREDERICK, MD, Aug. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has filed a 510(k), Premarket ...
Materials science and engineering researchers have experimentally verified the electrochemical processes that control charge transfer rate from an organic polymer to a biomarker molecule. Their ...
FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today ...
Ultra-thin crystalline silicon is an exciting material for next-generation bioelectronics, transforming rigid silicon into flexible nanomembranes while preserving superior electrical performance and ...
Researchers at the University of California, Los Angeles have taken a major step in enabling direct fabrication of hydrogel bioelectronics within tissues. Due to their structural similarities with ...
FREDERICK, MD , May 11, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to report on the outcome of its Pre-Submission meeting on May 9 th, 2018 with ...
Newark, New Castle, USA, Feb. 03, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global bioelectronics market is expected to clock US$ 25.27 billion by ...
FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting.